You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) to Swedish Orphan Biovitrum AB (Sobi). Sobi will commercialise Synagis in the US and around 130 AstraZeneca emAlready a subscriber Login You have read…
Recipharm and Consort Medical have reached an agreement on the terms of a recommended cash offer by Recipharm Holdings Limited, a wholly-owned direct subsidiary of Recipharm, for Consort. The Board of Consort has confirmed its unanimous intention to recommend a cash offer for an equity value of GAlready a subscriber…
Sectra has acquired the Swedish company RxEye, which sells cloud-based IT services for efficient and secure remote viewing of medical images. The services are used, for example, by radiology, nuclear medicine and pathology departments, as well as by companies that sell teleradiology services. ThrAlready a subscriber Login You have read…
LINK Medical Research, based in Oslo, has acquired all shares in PCG Clinical Services, located in Uppsala. After this acquisition, LINK Medical as a group has more than 160 employees in Norway, Sweden, Denmark and Germany, reports the company. “PCG Clinical Services completes our span of ofAlready a subscriber Login…
